Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects

NCT00930670 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Rosuvastatin-omeprazole
DRUG: Rosuvastatin-pantoprazole
DRUG: Rosuvastatin-esomeprazole
DRUG: Rosuvastatin-ranitidine
DRUG: Atorvastatin-omeprazole
DRUG: Atorvastatin-pantoprazole
DRUG: Atorvastatin-esomeprazole
DRUG: Atorvastatin-ranitidine

Sponsor

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec